We directly compared KHYG-1 to TRAILv-KHYG-1 cells to determine if the TRAIL modification enhances the cytotoxic efficacy of NK cells against ovarian cancer cell lines. This evidence concerns the gene TNFSF10 and ovarian carcinoma.